Therapy News and Research

RSS

JAK inhibitors and tocilizumab elicit better response rates in VEXAS syndrome

New research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, found that JAK inhibitors (JAKi) and tocilizumab elicited better response rates in VEXAS syndrome compared to other targeted therapies.

7 Nov 2023

Daily fetal heart rate monitoring recommended for pregnant women with high anti-SSA/Ro antibodies

Physicians who care for pregnant women have long sought to identify which of their patients would most likely benefit from monitoring of their fetus's heart rate to catch early signs of their unborn child developing heart problems tied to the mother's immune system.

7 Nov 2023

Diagnosing early-stage lung cancer with CT screening improves survival rate

Diagnosing early-stage lung cancer with low-dose computed tomography (CT) screening drastically improves its cure rate measured over a 20-year period, according to a large-scale international study by Mount Sinai researchers published in Radiology.

7 Nov 2023

Study shows why only a subset of individuals exposed to trauma develop PTSD

A study by researchers at EPFL shows why only a subset of individuals exposed to trauma develop posttraumatic stress disorder (PTSD).

7 Nov 2023

Research brings the prospect of injection-free treatment closer for people with diabetes

A University of Alberta team has developed a new step to improve the process for creating insulin-producing pancreatic cells from a patient's own stem cells, bringing the prospect of injection-free treatment closer for people with diabetes.

7 Nov 2023

Study validates first-in-class AI-driven digital pathology colorectal cancer diagnostic tool

In a peer-reviewed study published today in Nature Communications, a team of scientists from French-American techbio Owkin and pathology labs in France present a blind validation of MSIntuit CRC, a first-in-class AI-driven digital pathology diagnostic developed by Owkin, as a pre-screening tool aimed at optimizing the precision of diagnosis and treatment of colorectal cancer.

7 Nov 2023

New rapid test for sperm damage may predict embryonic aneuploidy and improve reproductive outcomes

A rapid diagnostic method for double-strand breaks (DSBs), Sperm deoxyribonucleic acid (DNA) Fragmentation (SDF) Releasing Assay (SDFR).

7 Nov 2023

Game-changer for Parkinson’s therapy: Innovative neuroprosthesis enhances mobility and balance

Researchers designed a neuroprosthesis replicating the natural lumbosacral spinal activation during walking for Parkinson's disease (PD) patients.

7 Nov 2023

Contrary evidence: Mediterranean diet may not influence cholesterol levels, study suggests

The association between Mediterranean diet (MD) adherence and lipid profiles among disease-free community residents

7 Nov 2023

Gut health linked to Alzheimer's disease progression, experts urge dietary shift

The interactions between the gut microbiome, lipids, and Alzheimer’s disease (AD).

7 Nov 2023

New pathologic scoring system could help predict survival in lung cancer patients

A new pathologic scoring system that accurately assesses how much lung tumor is left after a patient receives presurgical cancer treatments can be used to predict survival, according to new research led by investigators at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center and the Mark Foundation Center for Advanced Genomics and Imaging at the Johns Hopkins University.

6 Nov 2023

Children need to be screened for vision problems as often as adults with sickle cell disease, study suggests

Sickle cell disease is a rare, inherited disorder in which the red blood cells become hard, sticky, and change shape, resembling the farm tool.

6 Nov 2023

Targeted drug may offer a new treatment option for patients with relapsed blood cancer

A new targeted drug, studied by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James), may offer a new treatment option for patients with blood cancers, including chronic lymphocytic leukemia (CLL) and Non-Hodgkin lymphoma (NHL) whose disease has stopped responding to standard treatments.

6 Nov 2023

Researchers announce a new genetic classification system for gastric cancer

Professor Sang Cheul Oh of the Division of Oncology/Hematology, Department of Internal Medicine, Korea University College of Medicine, Professor Sang‑Hee Kang of the Department of Surgery, Korea University's Guro Hospital, and Professor Sun Young Yim of the Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University College of Medicine announced a new genetic classification system for gastric cancer by a multicenter study with the University of Texas MD Anderson Cancer Center.

6 Nov 2023

Overcoming T-cell exhaustion: A new hope for CAR-T cell therapy

CAR-T cell therapy is a last hope for many patients with blood, bone marrow or lymph gland cancer when other treatments such as chemotherapy are unsuccessful.

6 Nov 2023

New study unveils Foxp3's role in regulatory T cell chromatin architecture

Regulatory T cells are specialized immune cells that suppress the immune response and prevent the body from attacking its own cells.

6 Nov 2023

Patients with chronic fatigue syndrome benefit from cognitive behavior therapy

Researchers from Amsterdam UMC and King's College London have shown that Cognitive Behavioral Therapy (CBT) is beneficial for those with ME/CFS.

6 Nov 2023

Transgender adults in rural US more likely to have cardiovascular disease risk factors

Transgender adults living in the rural Appalachian area of the U.S., were more likely to have cardiovascular disease risk factors, like tobacco use, obesity and high blood pressure, thank their cisgender peers, according to a preliminary study to be presented at the American Heart Association's Scientific Sessions 2023.

6 Nov 2023

Machine learning paves the way for precision medicine in UTI treatments

Machine learning (ML) algorithms that predict antibiotic resistance in complicated urinary tract infections.

6 Nov 2023

Genetic twist in gallstone disease may shield against heart attacks

Mendelian randomization suggests gallstone disease may lower heart attack risk; genetics play a key role in this protective effect.

5 Nov 2023

Therapy News and Research

JAK inhibitors and tocilizumab elicit better response rates in VEXAS syndrome

Daily fetal heart rate monitoring recommended for pregnant women with high anti-SSA/Ro antibodies

Diagnosing early-stage lung cancer with CT screening improves survival rate

Study shows why only a subset of individuals exposed to trauma develop PTSD

Research brings the prospect of injection-free treatment closer for people with diabetes

Study validates first-in-class AI-driven digital pathology colorectal cancer diagnostic tool

New rapid test for sperm damage may predict embryonic aneuploidy and improve reproductive outcomes

Game-changer for Parkinson’s therapy: Innovative neuroprosthesis enhances mobility and balance

Contrary evidence: Mediterranean diet may not influence cholesterol levels, study suggests

Gut health linked to Alzheimer's disease progression, experts urge dietary shift

New pathologic scoring system could help predict survival in lung cancer patients

Children need to be screened for vision problems as often as adults with sickle cell disease, study suggests

Targeted drug may offer a new treatment option for patients with relapsed blood cancer

Researchers announce a new genetic classification system for gastric cancer

Overcoming T-cell exhaustion: A new hope for CAR-T cell therapy

New study unveils Foxp3's role in regulatory T cell chromatin architecture

Patients with chronic fatigue syndrome benefit from cognitive behavior therapy

Transgender adults in rural US more likely to have cardiovascular disease risk factors

Machine learning paves the way for precision medicine in UTI treatments

Genetic twist in gallstone disease may shield against heart attacks

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News